Risk factors

Shuttle Pharmaceuticals Holdings (SHPH) risk factors

Item 1A of every Shuttle Pharmaceuticals Holdings, Inc. 10-K on file, and what changed from one year to the next. Readings are automated and can be wrong; check the filing for the exact wording.

Open SHPH in Gloom →
Shuttle Pharmaceuticals Holdings' chart, financials and news, free in your browser.Open SHPH in Gloom →
  • FY2025 10-K risk factors
    17 risks4 new36 dropped4 reworded

    Shuttle Pharmaceuticals added risks related to its Molecule.ai acquisition and ongoing Nasdaq listing compliance issues involving stockholders equity and bid price. The company dropped 36 general development and clinical trial risks.

    Filed Mar 31, 2026
  • FY2024 10-K risk factors
    49 risks

    Shuttle Pharmaceuticals has no commercial revenue and depends on developing early-stage candidates like Ropidoxuridine and HDAC inhibitors.

    Filed Feb 26, 2025